Latest TGA News | Page 2

Emyria secures ethics endorsement for MDMA authorised prescriber application
Why low-cost ketamine is still inaccessible to many with severe depression
Queensland doctors save tiny ‘warrior’ heart patient Menasheh
AMA supports major vaping reforms
Substitution approved for vigabatrin shortage
Covid vaccine: Janssen
A doomed regulatory regime with no teeth
TGA Product Information safety updates 13 September
Medical devices vigilance program pilot
Therapeutic Goods Approval 2023
TGA statement on discontinuation of Ordine
Covid vaccine safety report – 07-09-2023
Botox and fillers to come under greater scrutiny by the medical regulator. Will it be too little too late?
Scam alert 1 September
Changes to the regulation of sports supplements in medicinal dosage forms
TGA seizes 40,000 vapes as part of multi-agency operation in Queensland
Multi-million dollar money laundering investigation smashes illicit tobacco and vape supply
Big tobacco & social media called out undermining vaping control
Changes to choline salicylate access to start from 1 October 2023
Post-market review of facemasks closed
TGA Product Information safety updates 31 August
Product Information inserts are no longer required for injectable medicines administered by health professionals
Feedback sought on FMT exemption and draft guidance
Nius Development Pty Ltd fined $26,640 for allegedly importing unapproved cosmetic injectable products
EmpireLabz Australia Pty Ltd fined $115,500 for alleged unlawful advertising and supply of sport supplements
Covid vaccine safety report – 24-08-2023
New reporting requirements for medicine shortages
Not all mental health apps are helpful. Experts explain the risks, and how to choose one wisely
Covid vaccine safety report – 10-08-2023
World class care closer to home
Covid vaccine safety report – 27-07-2023
Notice published pursuant to an order of the Federal Court of Australia
Vaping products, medicinal cannabis and the wellness industry included in 2023-24 compliance and enforcement priorities
TGA Product Information safety updates 24 July
Compliance and education for listed medicines
Alzheimer’s drug donanemab has been hailed as a ‘turning point’ for treatment. But what does it mean for people with the disease?
Sensible approach for medtech clinical trials
More than thousand vapes seized in first week of blitz
Australia supporting safe, quality medicines in our region
Information on shortages of Ryzodeg 70/30 FlexTouch insulin prefilled pens
Expansion of Access to Medical Abortion Welcome Amid Calls for Further Work to Address Remaining Barriers to a Safe, Legal and Common Health Service
TGA changes improve women’s access to medical terminations
Vaping blitz starts today targeting illegal sales
Nation-wide removal of restrictions on pharmacists dispensing medicines improves access to medical terminations
RACGP welcomes TGA changes improving access to medical abortion across Australia
TGA decision on access to medical terminations
Nitrosamine risk assessment in Category 1 prescription medicine registration applications
Deadline for certain medical device reforms to be extended